Browsing O - Articles científics by Title

A Phase Ib/II Study of WNT974 + Encorafenib + Cetuximab in Patients With BRAF V600E-Mutant KRAS Wild-Type Metastatic Colorectal Cancer

Van Cutsem, Eric; GARRALDA, Elena; Tai, David; de Braud, Filippo Guglielmo Maria; Geva, Ravit; Elez, Elena ; Tabernero, Josep (Oxford University Press, 2023-03)

A phase Ib/II study of xentuzumab, an IGF-neutralising antibody, combined with exemestane and everolimus in hormone receptor-positive, HER2-negative locally advanced/metastatic breast cancer

Sablin, Marie-Paule; Bergh, Jonas; Im, Seock-Ah; Lu, Yen-Shen; Martínez, Noelia; Cortés Castan, Javier; Schmid, Peter (BMC, 2021-01-15)

A phase II study of retifanlimab (INCMGA00012) in patients with squamous carcinoma of the anal canal who have progressed following platinum-based chemotherapy (POD1UM-202)

Rao, S.; Anandappa, G.; Dahan, L.; Evesque, L.; Kim, S.; Capdevila Castillon, Jaume (Elsevier, 2022-08)

A phase III, randomized, open-label study (CONTACT-02) of cabozantinib plus atezolizumab versus second novel hormone therapy in patients with metastatic castration-resistant prostate cancer

Carles Galceran, Joan; Chowdhury, Simon; McGregor, Bradley; Merseburger, Axel; Agarwal, Neeraj; Azad, Arun (Future Medicine, 2022-03)

A plain language summary of results from the GARNET study of dostarlimab in patients with endometrial cancer

Gilbert, Lucy; Tinker, Anna; Brown, Jubilee; Mathews, Cara; Press, Joshua; OAKNIN, ANA (Future Medicine, 2023-08)

A Prospective Cohort of SARS-CoV-2-Infected Health Care Workers: Clinical Characteristics, Outcomes, and Follow-up Strategy

Nicolás, David; Camós-Carreras, Anna; Spencer, Felipe; Arenas, Andrea; Butori, Eugenia; Maymó, Pol; Pericàs Pulido, Juan Manuel (Oxford University Press, 2020-12-08)

A randomised phase 2 study comparing different dose approaches of induction treatment of regorafenib in previously treated metastatic colorectal cancer patients (REARRANGE trial)

Argilés Martinez, Guillem; Mulet Margalef, Nuria; Valladares-Ayerbes, Manuel; Viéitez, Jose Maria; Grávalos, Cristina; García-Alfonso, Pilar; Tabernero, Josep (Elsevier, 2022-12)

A randomized phase 2 study of sapanisertib in combination with paclitaxel versus paclitaxel alone in women with advanced, recurrent, or persistent endometrial cancer

Han, Sileny; Oza, Amit; Colombo, Nicoletta; Raspagliesi, Francesco; Wenham, Robert M.; OAKNIN, ANA (Elsevier, 2023-11)

A Randomized, Double-Blind Noninferiority Study to Evaluate the Efficacy of the Cabozantinib Tablet at 60 mg Per Day Compared with the Cabozantinib Capsule at 140 mg Per Day in Patients with Progressive, Metastatic Medullary Thyroid Cancer

Klochikhin, Arkadiy; Leboulleux, Sophie; Isaev, Pavel; Badiu, Corin; Robinson, Bruce; Capdevila Castillon, Jaume (Mary Ann Liebert, 2022-05)

A randomized, phase 2 study of deoxyuridine triphosphatase inhibitor, TAS-114, in combination with S-1 versus S-1 alone in patients with advanced non-small-cell lung cancer

Yamamoto, Nobuyuki; Morán, Teresa; Gregorc, Vanesa; Dowell, Jonathan; Cedres Perez, Susana; Planchard, David; Hayashi, Hidetoshi (Springer, 2020-10)

A Randomized, Phase III Trial to Evaluate Rucaparib Monotherapy as Maintenance Treatment in Patients With Newly Diagnosed Ovarian Cancer (ATHENA–MONO/GOG-3020/ENGOT-ov45)

Monk, Bradley J.; Parkinson, Christine; Lim, Myong Cheol; O’Malley, David M.; Oaknin Benzaquen, Ana Mazaltob; Wilson, Michelle (Lippincott Williams & Wilkins, 2022-12-01)

A retrospective validation of CanAssist Breast in European early-stage breast cancer patient cohort

Gunda, Aparna; Basavaraj, Chetana; Pradhan, Prakash Chandra; Adinarayan, Manjula; Kolli, Ramu; Siraganahalli Eshwaraiah, Mallikarjuna; Ruiz Pace, Fiorella; Gómez Pardo, Patricia; Jiménez Flores, José Antonio; Saura Manich, Cristina; Peg, Vicente (Elsevier, 2022-06)

A signature of circulating microRNAs predicts the response to treatment with FOLFIRI plus aflibercept in metastatic colorectal cancer patients

Toledano, Marta; Gómez España, Maria Auxiliadora; Elez Fernandez, Mª Elena; Grávalos, Cristina; García-Alfonso, P.; Rodríguez, R.; Tabernero Caturla, Josep (Elsevier, 2023-03)

A single-arm study design with non-inferiority and superiority time-to-event endpoints: a tool for proof-of-concept and de-intensification strategies in breast cancer

Sampayo-Cordero, Miguel; Miguel-Huguet, Bernat; Malfettone, Andrea; López-Miranda, Elena; Gion, María; Abad, Elena; Cortes, Javier (Frontiers Media, 2023-07-11)

A transcriptomics approach to expand therapeutic options and optimize clinical trials in oncology

Lazar, Vladimir; Zhang, Baolin; Magidi, Shai; Raymond, Eric; Ducreux, M.; Felip Font, Enriqueta; Tabernero Caturla, Josep; Le Tourneau, Christophe (SAGE Publications, 2023)

A WIN Consortium phase I study exploring avelumab, palbociclib, and axitinib in advanced non-small cell lung cancer

Callejo Perez, Ana; Bar, Jair; Berchem, Guy; Bazhenova, Lyudmila; Saintigny, Pierre; Felip Font, Enriqueta; Solomon, Benjamin (Wiley, 2022-07)

Abemaciclib Combined With Endocrine Therapy for the Adjuvant Treatment of HR+, HER2−, Node-Positive, High-Risk, Early Breast Cancer (monarchE)

Johnston, Stephen RD; Harbeck, Nadia; Hegg, Roberto; Toi, Masakazu; Martin, Miguel; Shao, Zhi Min; Cortés Castan, Javier (American Society of Clinical Oncology, 2020-12-01)

Acquired cancer cell resistance to T cell bispecific antibodies and CAR T targeting HER2 through JAK2 down-modulation

Román Alonso, Macarena; Escorihuela Baez, Marta; Luque García, Antonio; Fajardo, Carlos Alberto; Gros Vidal, Alena; Arribas López, Joaquin Vicente; Arenas Lahuerta, Enrique Javier; Martínez-Sabadell, Alex; Rius Ruiz, Irene (Nature Research, 2021-02-23)

Acquired hepatocerebral degeneration in a metastatic neuroendocrine tumor long-term survivor - an update on neuroendocrine neoplasm's treatment: A case report

Mirallas Viñas, Oriol; Gomez-Puerto, Diego; Riveiro Barciela, Maria del Mar; Merino Casabiel, Xavier; Auger Acosta, Cristina; García Burillo, Amparo; Molero Richard, Francesc Xavier; Salcedo Allende, Maria Teresa; Capdevila Castillon, Jaume; Landolfi, Stefania; Saoudi Gonzalez, Nadia; Blanco Cuso, Laia (Baishideng Publishing Group, 2021-05-27)

ACT-Discover: identifying karyotype heterogeneity in pancreatic cancer evolution using ctDNA

Huebner, Ariana; Black, James R. M.; Sarno, Francesca; Pazo, Roberto; Juez, Ignacio; MEDINA RODRIGUEZ, LAURA; Arenillas, Carlota; Moreno-Cárdenas, Ana Belén; Verdaguer, Helena; Macarulla, Teresa; Toledo, Rodrigo (BMC, 2023-04-20)

Scientia. Dipòsit d'Informació Digital del Departament de Salut

Browsing VHIO - Articles científics by Title

A Phase Ib/II Study of WNT974 + Encorafenib + Cetuximab in Patients With BRAF V600E-Mutant KRAS Wild-Type Metastatic Colorectal Cancer

A phase Ib/II study of xentuzumab, an IGF-neutralising antibody, combined with exemestane and everolimus in hormone receptor-positive, HER2-negative locally advanced/metastatic breast cancer

A phase II study of retifanlimab (INCMGA00012) in patients with squamous carcinoma of the anal canal who have progressed following platinum-based chemotherapy (POD1UM-202)

A phase III, randomized, open-label study (CONTACT-02) of cabozantinib plus atezolizumab versus second novel hormone therapy in patients with metastatic castration-resistant prostate cancer

A plain language summary of results from the GARNET study of dostarlimab in patients with endometrial cancer

A Prospective Cohort of SARS-CoV-2-Infected Health Care Workers: Clinical Characteristics, Outcomes, and Follow-up Strategy

A randomised phase 2 study comparing different dose approaches of induction treatment of regorafenib in previously treated metastatic colorectal cancer patients (REARRANGE trial)

A randomized phase 2 study of sapanisertib in combination with paclitaxel versus paclitaxel alone in women with advanced, recurrent, or persistent endometrial cancer

A Randomized, Double-Blind Noninferiority Study to Evaluate the Efficacy of the Cabozantinib Tablet at 60 mg Per Day Compared with the Cabozantinib Capsule at 140 mg Per Day in Patients with Progressive, Metastatic Medullary Thyroid Cancer

A randomized, phase 2 study of deoxyuridine triphosphatase inhibitor, TAS-114, in combination with S-1 versus S-1 alone in patients with advanced non-small-cell lung cancer

A Randomized, Phase III Trial to Evaluate Rucaparib Monotherapy as Maintenance Treatment in Patients With Newly Diagnosed Ovarian Cancer (ATHENA–MONO/GOG-3020/ENGOT-ov45)

A retrospective validation of CanAssist Breast in European early-stage breast cancer patient cohort

A signature of circulating microRNAs predicts the response to treatment with FOLFIRI plus aflibercept in metastatic colorectal cancer patients

A single-arm study design with non-inferiority and superiority time-to-event endpoints: a tool for proof-of-concept and de-intensification strategies in breast cancer

A transcriptomics approach to expand therapeutic options and optimize clinical trials in oncology

A WIN Consortium phase I study exploring avelumab, palbociclib, and axitinib in advanced non-small cell lung cancer

Abemaciclib Combined With Endocrine Therapy for the Adjuvant Treatment of HR+, HER2−, Node-Positive, High-Risk, Early Breast Cancer (monarchE)

Acquired cancer cell resistance to T cell bispecific antibodies and CAR T targeting HER2 through JAK2 down-modulation

Acquired hepatocerebral degeneration in a metastatic neuroendocrine tumor long-term survivor - an update on neuroendocrine neoplasm's treatment: A case report

ACT-Discover: identifying karyotype heterogeneity in pancreatic cancer evolution using ctDNA

Know Scientia

Guides and help

Go to...

Know Scientia

Guides and help

Go to...

Browsing VHIO - Articles científics by Title

A Phase Ib/II Study of WNT974 + Encorafenib + Cetuximab in Patients With BRAF V600E-Mutant KRAS Wild-Type Metastatic Colorectal Cancer ﻿

A phase Ib/II study of xentuzumab, an IGF-neutralising antibody, combined with exemestane and everolimus in hormone receptor-positive, HER2-negative locally advanced/metastatic breast cancer ﻿

A phase II study of retifanlimab (INCMGA00012) in patients with squamous carcinoma of the anal canal who have progressed following platinum-based chemotherapy (POD1UM-202) ﻿

A phase III, randomized, open-label study (CONTACT-02) of cabozantinib plus atezolizumab versus second novel hormone therapy in patients with metastatic castration-resistant prostate cancer ﻿

A plain language summary of results from the GARNET study of dostarlimab in patients with endometrial cancer ﻿

A Prospective Cohort of SARS-CoV-2-Infected Health Care Workers: Clinical Characteristics, Outcomes, and Follow-up Strategy ﻿

A randomised phase 2 study comparing different dose approaches of induction treatment of regorafenib in previously treated metastatic colorectal cancer patients (REARRANGE trial) ﻿

A randomized phase 2 study of sapanisertib in combination with paclitaxel versus paclitaxel alone in women with advanced, recurrent, or persistent endometrial cancer ﻿

A Randomized, Double-Blind Noninferiority Study to Evaluate the Efficacy of the Cabozantinib Tablet at 60 mg Per Day Compared with the Cabozantinib Capsule at 140 mg Per Day in Patients with Progressive, Metastatic Medullary Thyroid Cancer ﻿

A randomized, phase 2 study of deoxyuridine triphosphatase inhibitor, TAS-114, in combination with S-1 versus S-1 alone in patients with advanced non-small-cell lung cancer ﻿

A Randomized, Phase III Trial to Evaluate Rucaparib Monotherapy as Maintenance Treatment in Patients With Newly Diagnosed Ovarian Cancer (ATHENA–MONO/GOG-3020/ENGOT-ov45) ﻿

A retrospective validation of CanAssist Breast in European early-stage breast cancer patient cohort ﻿

A signature of circulating microRNAs predicts the response to treatment with FOLFIRI plus aflibercept in metastatic colorectal cancer patients ﻿

A single-arm study design with non-inferiority and superiority time-to-event endpoints: a tool for proof-of-concept and de-intensification strategies in breast cancer ﻿

A transcriptomics approach to expand therapeutic options and optimize clinical trials in oncology ﻿

A WIN Consortium phase I study exploring avelumab, palbociclib, and axitinib in advanced non-small cell lung cancer ﻿

Abemaciclib Combined With Endocrine Therapy for the Adjuvant Treatment of HR+, HER2−, Node-Positive, High-Risk, Early Breast Cancer (monarchE) ﻿

Acquired cancer cell resistance to T cell bispecific antibodies and CAR T targeting HER2 through JAK2 down-modulation ﻿

Acquired hepatocerebral degeneration in a metastatic neuroendocrine tumor long-term survivor - an update on neuroendocrine neoplasm's treatment: A case report ﻿

ACT-Discover: identifying karyotype heterogeneity in pancreatic cancer evolution using ctDNA ﻿

Know Scientia

Guides and help

Go to...

Know Scientia

Guides and help

Go to...

A Phase Ib/II Study of WNT974 + Encorafenib + Cetuximab in Patients With BRAF V600E-Mutant KRAS Wild-Type Metastatic Colorectal Cancer

A phase Ib/II study of xentuzumab, an IGF-neutralising antibody, combined with exemestane and everolimus in hormone receptor-positive, HER2-negative locally advanced/metastatic breast cancer

A phase II study of retifanlimab (INCMGA00012) in patients with squamous carcinoma of the anal canal who have progressed following platinum-based chemotherapy (POD1UM-202)

A phase III, randomized, open-label study (CONTACT-02) of cabozantinib plus atezolizumab versus second novel hormone therapy in patients with metastatic castration-resistant prostate cancer

A plain language summary of results from the GARNET study of dostarlimab in patients with endometrial cancer

A Prospective Cohort of SARS-CoV-2-Infected Health Care Workers: Clinical Characteristics, Outcomes, and Follow-up Strategy

A randomised phase 2 study comparing different dose approaches of induction treatment of regorafenib in previously treated metastatic colorectal cancer patients (REARRANGE trial)

A randomized phase 2 study of sapanisertib in combination with paclitaxel versus paclitaxel alone in women with advanced, recurrent, or persistent endometrial cancer

A Randomized, Double-Blind Noninferiority Study to Evaluate the Efficacy of the Cabozantinib Tablet at 60 mg Per Day Compared with the Cabozantinib Capsule at 140 mg Per Day in Patients with Progressive, Metastatic Medullary Thyroid Cancer

A randomized, phase 2 study of deoxyuridine triphosphatase inhibitor, TAS-114, in combination with S-1 versus S-1 alone in patients with advanced non-small-cell lung cancer

A Randomized, Phase III Trial to Evaluate Rucaparib Monotherapy as Maintenance Treatment in Patients With Newly Diagnosed Ovarian Cancer (ATHENA–MONO/GOG-3020/ENGOT-ov45)

A retrospective validation of CanAssist Breast in European early-stage breast cancer patient cohort

A signature of circulating microRNAs predicts the response to treatment with FOLFIRI plus aflibercept in metastatic colorectal cancer patients

A single-arm study design with non-inferiority and superiority time-to-event endpoints: a tool for proof-of-concept and de-intensification strategies in breast cancer

A transcriptomics approach to expand therapeutic options and optimize clinical trials in oncology

A WIN Consortium phase I study exploring avelumab, palbociclib, and axitinib in advanced non-small cell lung cancer

Abemaciclib Combined With Endocrine Therapy for the Adjuvant Treatment of HR+, HER2−, Node-Positive, High-Risk, Early Breast Cancer (monarchE)

Acquired cancer cell resistance to T cell bispecific antibodies and CAR T targeting HER2 through JAK2 down-modulation

Acquired hepatocerebral degeneration in a metastatic neuroendocrine tumor long-term survivor - an update on neuroendocrine neoplasm's treatment: A case report

ACT-Discover: identifying karyotype heterogeneity in pancreatic cancer evolution using ctDNA